▼ SELL
10b5-1 Plan
$ Value
$901K
Shares
75,000
Price
$12
Filed
Feb 26
Insider
Name
Simon Barry J.
Title
—
CIK
0001647994
Roles
Director
Transaction Details
Transaction Date
2026-02-24
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
2,850,821
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024. | Represents the weighted average share price of an aggregate total of 75,000 shares sold in the price range of $12.00 to $12.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Filing Info
Simon Barry J.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-24 | IBRX | ▼ | $901K |
| 2026-02-23 | IBRX | ▼ | $1.7M |
| 2026-02-22 | IBRX | M | $0 |
| 2026-02-22 | IBRX | F | $52K |
| 2026-02-22 | IBRX | M | $0 |
| 2026-02-20 | IBRX | ▼ | $92K |
| 2026-01-20 | IBRX | ▼ | $503K |
| 2026-01-20 | IBRX | ▼ | $591K |
Other Insiders at IBRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SOON-SHIONG PATRICK
See remarks
|
— | — | 2026-03-31 |
|
LAUER REGAN J
Chief Accounting Officer
|
— | — | 2026-02-22 |
| Simon Barry J. | — | $1.8M | 2026-02-23 |
|
Adcock Richard
CEO & President
|
— | — | 2026-02-22 |
|
Sachs David C.
Chief Financial Officer
|
— | — | 2026-02-22 |
| Selecky Christobel | — | $250K | 2026-02-23 |